HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isa M Bernardini Selected Research

Rufous oculocutaneous albinism

10/2018Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isa M Bernardini Research Topics

Disease

2Oculocutaneous Albinism (Albinism, Yellow Mutant)
10/2018 - 10/2011
1Rufous oculocutaneous albinism
10/2018
1Cystinosis
05/2012
1Oculocutaneous albinism type 1
10/2011
1Dent Disease 2
03/2011

Drug/Important Bio-Agent (IBA)

2nitisinone (Orfadin)FDA Link
10/2018 - 10/2011
2Monophenol Monooxygenase (Tyrosinase)IBA
10/2018 - 10/2011
1Cystine (L-Cystine)IBA
05/2012
1Melanins (Melanin)IBA
10/2011
1Phosphatidylinositols (Phosphatidylinositol)IBA
03/2011